Please check your internet connection and try again.
# Methycobalime (Methylcobalamin)
## Overview
Methycobalime is a brand name for methylcobalamin, an active form of vitamin B12. It is essential for DNA synthesis, red blood cell formation, and neurological function.
## Primary Indications
* Vitamin B12 deficiency (e.g., pernicious anemia, malabsorption syndromes).
* Management of peripheral neuropathy.
## Adult Dosing
* **Vitamin B12 Deficiency:**
* Parenteral: 1000 mcg intramuscularly (IM) daily for 1 week, then 1000 mcg IM every week for 1 month, followed by 1000 mcg IM every 1-3 months for maintenance. Dosing may vary based on severity and etiology.
* Oral: Doses vary widely, often 1000-2000 mcg daily. Oral therapy may be less effective in severe malabsorption.
* **Peripheral Neuropathy:** Doses vary. Common regimens include 1000-2000 mcg daily orally or IM. Specific dosing may depend on the underlying cause and local protocol.
## Pediatric Dosing
* **Vitamin B12 Deficiency:** Dosing is weight-based and age-dependent. Typical parenteral doses range from 50-100 mcg IM daily for infants and children up to 1000 mcg IM weekly for older children. Oral doses are often 50-100 mcg daily. Exact pediatric dosing should be guided by established guidelines or a pediatric specialist.
## Dose Adjustments
* No dose adjustments are typically required for renal or hepatic impairment, as methylcobalamin is not significantly metabolized or excreted by these organs.
## Contraindications
* Hypersensitivity to methylcobalamin or other cobalt-containing compounds.
## Adverse Effects
* Generally well-tolerated.
* Rare: Rash, itching, allergic reactions.
## Key Drug Interactions
* **Chloramphenicol:** May interfere with the hematopoietic response to vitamin B12 therapy.
* **Folic Acid:** High doses of folic acid can mask the hematological signs of vitamin B12 deficiency, potentially leading to irreversible neurological damage.
## Monitoring
* Complete blood count (CBC) to assess response in deficiency states.
* Serum vitamin B12 levels (though clinical response is often more important than absolute levels).
* Neurological status for improvement in neuropathy symptoms.
## Clinical Pearls
* Methylcobalamin is the active coenzyme form of vitamin B12, meaning it does not require metabolic conversion and may be preferred in certain deficiency states.
* Parenteral administration is generally preferred for initial treatment of severe deficiency or malabsorption.
* Monitor for neurological improvement, as this is a key indicator of treatment efficacy.
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for professional medical advice. Always consult the most current prescribing information and guidelines for complete details before making any treatment decisions.
